MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0025330
Keminterpharm Spechem Resources Private Limited - chemicals and materials in Vasai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.58 Cr
▲ 11% YoY
Net profit · FY 2024
₹62.74 Lakh
Net margin 7.3%
EBITDA · FY 2024
₹95.61 Lakh
EBITDA margin 11.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹24.99 Lakh
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
About Keminterpharm Spechem Resources Private Limited
Data last updated:
Keminterpharm Spechem Resources Private Limited is a private limited company based in Vasai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 25 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2004PTC146526. Its GSTIN is 27AACCK3840P1Z5 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Kiran Light Laboratories Private Limited. It is led by directors Rekha Kiran Oza and Kiran Shivshankar Oza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 – 202 Prathamm Industrial Estate 2nd Floor National Highway 8 Sativali Vasai Eas, T, Maharashtra, India – 401208.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.58 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹62.74 Lakh (net margin 7.3%) and EBITDA of ₹95.61 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 116% over five years.
As per MCA filings, the company has open charges of ₹24.99 Lakh on record.
Keminterpharm Spechem Resources Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0025330). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keminterpharm.com.
Company details
CIN U24100MH2004PTC146526
Registration Number 146526
Incorporation Date 25 May 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0025330
Recognitions & Rankings of Keminterpharm Spechem Resources
Contact details
Keminterpharm Spechem Resources Private Limited's registered office is in Vasai, Maharashtra. Its website is keminterpharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address201 – 202 Prathamm Industrial Estate 2nd Floor National Highway 8 Sativali Vasai Eas, T, Maharashtra, India – 401208
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Keminterpharm Spechem Resources Private Limited, buy the company report.
Comprehensive company report
Keminterpharm Spechem Resources Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Keminterpharm Spechem Resources is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Keminterpharm Spechem Resources Private Limited, buy the company report.
Financials of Keminterpharm Spechem Resources Private Limited
FY 2025 filings availableKeminterpharm Spechem Resources Private Limited reported revenue of ₹8.58 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹8.58 Cr ▲ 11%
Net profit · FY 2024
₹62.74 Lakh margin 7.3%
EBITDA · FY 2024
₹95.61 Lakh margin 11.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 25%
5 years · compounded
▲ 116%
EBITDA CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 43%
5 years · compounded
▲ 115%
Revenue has grown at a compounded annual rate (CAGR) of 116% over five years, including 11% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹95.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Keminterpharm Spechem Resources Private Limited, buy the company report.
Board of directors of Keminterpharm Spechem Resources Private Limited
Keminterpharm Spechem Resources has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Kiran Oza | Director | 10 Aug 2016 | 10 Years 2 Months | Current |
| Kiran Shivshankar Oza Also directs: Princess Pharma Private Limited | Director | 29 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Keminterpharm Spechem Resources Private Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kayavlon Impex Private Limited | ₹8.63 Cr (FY 2025) | -30.0% | Surat, Gujarat, India | |||
| Iwasa Chemical Private Limited | ₹8.61 Cr (FY 2024) | 12.0% | Surat, Gujarat, India | |||
| Highpoint Tradelink Private Limited | ₹8.61 Cr (FY 2025) | 1816.0% | Kolkata, West Bengal, India | |||
| Keminterpharm Spechem Resources Private Limitedthis company | ₹8.58 Cr (FY 2024) | ₹62.74 Lakh | 7.3% | 11.0% | Vasai, Maharashtra, India | |
| Arbit Enterprises Private Limited | ₹8.56 Cr (FY 2025) | -8.0% | Uttar Pradesh, India | |||
| Respa Textiles Private Limited | ₹8.56 Cr (FY 2024) | 45.0% | New Delhi, Delhi, India | |||
| Thyme India Private Limited | ₹8.53 Cr (FY 2024) | 62.0% | Rourkela, Odisha, India | |||
| Liberty Natural Weaves Private Limited | ₹8.52 Cr (FY 2025) | 179.0% | Surat, Gujarat, India |
To see the full peer comparison of Keminterpharm Spechem Resources Private Limited, buy the company report.
Auditor
Keminterpharm Spechem Resources Private Limited is audited by AMOL DANDEKAR & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMOL DANDEKAR & ASSOCIATES | FY 2020 | 141552W |
Shareholding
The shareholding of Keminterpharm Spechem Resources Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Keminterpharm Spechem Resources Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.99 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Oct 2021 | 100511972 | Hdfc Bank Limited | ₹24.99 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Keminterpharm Spechem Resources Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Keminterpharm Spechem Resources Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Keminterpharm Spechem Resources has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCK3840P1Z5 | Maharashtra | Active | 01 Jul 2017 |
| 24AACCK3840P1ZB | Gujarat | Active | 14 Sep 2021 |
To see the full GST registrations and return filing status of Keminterpharm Spechem Resources Private Limited, buy the company report.
Recent activity
Keminterpharm Spechem Resources Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Kiran Shivshankar Oza ceased to be Additional Director on 30 Sep 2019.
AGM
Keminterpharm Spechem Resources Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Keminterpharm Spechem Resources Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.99 Lakh with Charge ID 100511972 was registered on 07 Oct 2021.
Ceased
Kiran Shivshankar Oza ceased to be Additional Director.
Ceased
Khyati Sandeep Oza ceased to be Director.
Appointed
Kiran Shivshankar Oza was appointed as Director.
Appointed
Rekha Kiran Oza was appointed as Director.
Ceased
Sandeep Shivshankar Oza ceased to be Director.
Incorporation
25 May 2004
Keminterpharm Spechem Resources Private Limited was registered on 25 May 2004 with Roc Mumbai I & aged 22 years 5 months as per MCA records.
Frequently asked questions
Keminterpharm Spechem Resources is an active private limited company based in Vasai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 25 May 2004 (22+ years old) and is registered under CIN U24100MH2004PTC146526.
Keminterpharm Spechem Resources has 2 current directors:
- Rekha Kiran Oza - Director
- Kiran Shivshankar Oza - Director
The latest financial statements of Keminterpharm Spechem Resources on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Keminterpharm Spechem Resources is 27AACCK3840P1Z5, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AACCK3840P1ZB (Gujarat).
The CIN (Corporate Identification Number) of Keminterpharm Spechem Resources is U24100MH2004PTC146526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Keminterpharm Spechem Resources was incorporated on 25 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Keminterpharm Spechem Resources by revenue are Kayavlon Impex Private Limited, Iwasa Chemical Private Limited, Highpoint Tradelink Private Limited, Arbit Enterprises Private Limited, Respa Textiles Private Limited and 2 more, all in the Chemicals industry (Chemical Retail and Distribution), with the same principal business activity (wholesale trading).
Kiran Shivshankar Oza ceased to be Additional Director on 30 Sep 2019. Khyati Sandeep Oza ceased to be Director on 29 May 2019. Kiran Shivshankar Oza was appointed as Director on 29 May 2019. Keminterpharm Spechem Resources has 5 board changes on record in total.
Yes, Keminterpharm Spechem Resources is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0025330).
Keminterpharm Spechem Resources can be reached through the website keminterpharm.com. Its registered office is in Vasai, Maharashtra, India.
The registered office of Keminterpharm Spechem Resources is at 201 – 202 Prathamm Industrial Estate 2nd Floor National Highway 8 Sativali Vasai Eas, T, Maharashtra, India – 401208.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages